Search results

Selected filters:

News
Law & Policy

Article type

Topic

Sector

Regions

Year

356 results found for your search

Sort options
19 October 2019

Why the Red Hat tail will end up wagging the Big Blue dog

IBM's decision to purchase the open source powerhouse was a $34 billion bet on the future and from an IP perspective something has to give

10 October 2019

Patent term adjustments in the US are readjusted, again

Two recent Federal Circuit decisions have shed further light on a highly litigated area of biopharma patent law

05 October 2019

The USPTO seeks AI expertise to change the rules of the game internally and externally

New role has the potential to deliver results that will enhance internal processes, improve quality, lower costs and help recover lost US influence in the international IP arena

01 October 2019

The top biopharma patent stories in September

Our round-up of all the major IP developments affecting the life sciences industries last month

30 September 2019

Europe and Latin America moving to marriage, but IP could be grounds for divorce

The recent trade accord agreed in principle between the EU and Mercosur promises to deliver significant benefits, but political controversies around issues such as data protection and SPCs mean that the deal is not yet sealed

28 September 2019

The US is gifting 5G patent leadership to others

Policy confusion and problematic court decisions mean that the shape of the IP landscape in this pivotal technology is being determined elsewhere

25 September 2019

Copyright clarification from Europe’s top court

Judges at the Court of Justice of the European Union delivered good news for designers in their Cofomel decision earlier this month

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

17 September 2019

Australia’s harsh approach to software patents set to continue

Observers had hoped Friday’s decision in the Encompass case would clarify key patentability questions. But a Full Bench of the Federal Court of Australia did not take the opportunity to do so

13 September 2019

Patent litigation is one reason why the UK will remain in the legal premier league

Despite the pervading sense of gloom, the quality of English courts and lawyers - and the remedies now available to plaintiffs - mean that there is an IP bright spot amidst the carnage of Brexit

11 September 2019

Five things to watch for from Japan’s new IP policy leadership

The new commissioner of the JPO and top cabinet advisor on IP will both address IPBC Asia in Tokyo in some of their first appearances in front of a global audience

07 September 2019

For the US Defense Department, China is not the IP problem – data is

Despite the claims being made by politicians, a re-engineered IP strategy at the Pentagon has little to do with theft and everything to do with trade secrets

07 September 2019

Life sciences IP - the major developments in August

All the big pharma and biotech patent stories from last month in our regular monthly round-up

21 August 2019

US removes 5G work exemption from Huawei ban

The Commerce Department extended Huawei’s temporary licence yesterday, but it dropped a provision that allowed technology sharing as part of 5G standards development

14 August 2019

USPTO Director Iancu set to keynote IAM’s patent litigation event as 101 legislation debate continues

American Express, Nokia, Google, Nasdaq, Volkswagen, Novartis and Merck executives among the final speakers revealed for prestigious November conference in Washington DC